Lobe Sciences Ltd. (LOBEF) Research

Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.

Market snapshot

Symbol
LOBEF
Price
$0.01
Day change
-1.54%
Market cap
$15.5M
P/E ratio
-3.83x
52-week range
0.0019-0.064
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 6 months

Peer companies

  • Australis Capital Inc. (AUSAF)
  • Blueberries Medical Corp. (BBRRF)
  • WEED, Inc. (BUDZ)
  • Trees Corporation (CANN)
  • Cannabis Bioscience International Holdings, Inc. (CBIH)
  • CV Sciences, Inc. (CVSI)
  • Ionic Brands Corp. (IONKF)
  • PharmaCielo Ltd. (PCLOF)

Open Lobe Sciences Ltd. (LOBEF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.